The free energies of binding, DeltaG(bind), between a diverse set of eight hydroxamate inhibitors with gelatinase-A (MMP-2) were computed by using the recently developed MM/PBSA approach. In this paper, a nonbonded model was used to represent the potentials of the catalytic zinc center. Molecular dynamics (MD) simulations were used to generate the thermally averaged ensemble of conformations of the ligand-protein complexes. On the basis of the trajectories from MD simulations, the free energies of binding were calculated using molecular mechanics, the continuum solvent model, surface area estimation, and normal-mode analysis. The results show that MM/PBSA not only can rank the studied ligands effectively but also can reproduce the experimen...
Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases involved in the ext...
In the drug discovery process, accurate methods of computing the affinity of small molecules with a ...
Most drugs act on biomacromolecules. The Cost of developing new drugs is very high. A method to accu...
The binding of a series of hydroxamate inhibitors with gelatinase-A is examined to evaluate the viab...
The binding of a series of hydroxamate inhibitors with gelatinase-A is examined to evaluate the viab...
We have performed docking and molecular dynamics simulations of hydroxamates complexed with human ge...
Here we report molecular dynamics (MD) and free energy perturbation (FEP) simulations applied to hyd...
Matrix metalloproteinases (MMP) are well-known biological targets implicated in tumour progression, ...
A gelastatins (1), natural MMP inhibitors, and their hydroxamate analogues (2) in TACE enzyme evalua...
Matrix metalloproteinases (MMP) are well-known biological targets implicated in tumour progression, ...
Matrix metalloproteinases (MMPs) represent a potentially important class of therapeutic targets for ...
Accurate calculations of free energies for molecular association and solvation are important for the...
<div><p>Matrix metalloproteinases are a family of Zn-proteases involved in tissue remodeling and in ...
Despite the development of high-throughput computational methods able to screen very large libraries...
Understanding binding mechanisms between enzymes and potential inhibitors and quantifying protein-li...
Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases involved in the ext...
In the drug discovery process, accurate methods of computing the affinity of small molecules with a ...
Most drugs act on biomacromolecules. The Cost of developing new drugs is very high. A method to accu...
The binding of a series of hydroxamate inhibitors with gelatinase-A is examined to evaluate the viab...
The binding of a series of hydroxamate inhibitors with gelatinase-A is examined to evaluate the viab...
We have performed docking and molecular dynamics simulations of hydroxamates complexed with human ge...
Here we report molecular dynamics (MD) and free energy perturbation (FEP) simulations applied to hyd...
Matrix metalloproteinases (MMP) are well-known biological targets implicated in tumour progression, ...
A gelastatins (1), natural MMP inhibitors, and their hydroxamate analogues (2) in TACE enzyme evalua...
Matrix metalloproteinases (MMP) are well-known biological targets implicated in tumour progression, ...
Matrix metalloproteinases (MMPs) represent a potentially important class of therapeutic targets for ...
Accurate calculations of free energies for molecular association and solvation are important for the...
<div><p>Matrix metalloproteinases are a family of Zn-proteases involved in tissue remodeling and in ...
Despite the development of high-throughput computational methods able to screen very large libraries...
Understanding binding mechanisms between enzymes and potential inhibitors and quantifying protein-li...
Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases involved in the ext...
In the drug discovery process, accurate methods of computing the affinity of small molecules with a ...
Most drugs act on biomacromolecules. The Cost of developing new drugs is very high. A method to accu...